Azamian Bobak R. 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Sep 26, 2025
Insider Transaction Report
Form 4
Azamian Bobak R.
DirectorPresident/CEO and Board Chair
Transactions
- Sale
Common Stock
2025-09-24$55.37/sh−6,000$332,220→ 812,106 total(indirect: By Trust)
Holdings
- 53,635
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024.
- [F2]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $55.19 to $55.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.